Bots, editor, reviewer, Administrators
13,951
edits
No edit summary |
No edit summary |
||
Line 282: | Line 282: | ||
* [[PRORATA]] (2010): Procalcitonin-guided antibiotics | * [[PRORATA]] (2010): Procalcitonin-guided antibiotics | ||
* [[SAFE]] (2004): Albumin vs. saline in ICU | * [[SAFE]] (2004): Albumin vs. saline in ICU | ||
* [[Yang-Tobin Study]] (1991): RSBI for predicting weaning | * [[Yang-Tobin Study]] (1991): RSBI for predicting weaning | ||
Line 383: | Line 382: | ||
'''Chronic Kidney Disease''' | '''Chronic Kidney Disease''' | ||
* [[TREAT]] (2009): Darbepoetin in CKD and T2DM | * [[TREAT]] (2009): Darbepoetin in CKD and T2DM | ||
Line 404: | Line 402: | ||
* [[Look AHEAD]] (2013): Weight loss and exercise in T2DM | * [[Look AHEAD]] (2013): Weight loss and exercise in T2DM | ||
* [[ONTARGET]] (2008): Ramipril vs. telmisartan vs. both in CVD, stroke, PAD, or DM | * [[ONTARGET]] (2008): Ramipril vs. telmisartan vs. both in CVD, stroke, PAD, or DM | ||
* [[TREAT]] (2009): Darbepoetin in CKD and T2DM | * [[TREAT]] (2009): Darbepoetin in CKD and T2DM | ||
* [[UKPDS 33]] (1998): Intensive glycemic therapy in T2DM | * [[UKPDS 33]] (1998): Intensive glycemic therapy in T2DM | ||
Line 419: | Line 415: | ||
'''Menopause''' | '''Menopause''' | ||
* [[WHI]] (2002): Postmenopausal estrogen/progesterone | * [[WHI]] (2002): Postmenopausal estrogen/progesterone | ||
'''Sepsis''' | '''Sepsis''' | ||
Line 637: | Line 630: | ||
* [[IDEAL]] (2010): Early vs. late dialysis in CKD | * [[IDEAL]] (2010): Early vs. late dialysis in CKD | ||
* [[NCDS]] (1981): Dialysis prescriptions in ESRD | * [[NCDS]] (1981): Dialysis prescriptions in ESRD | ||
* [[TREAT]] (2009): Darbepoetin in CKD and T2DM | * [[TREAT]] (2009): Darbepoetin in CKD and T2DM | ||
Line 647: | Line 639: | ||
* [[IDNT]] (2001): ARBs in diabetic nephropathy | * [[IDNT]] (2001): ARBs in diabetic nephropathy | ||
* [[ONTARGET]] (2008): Ramipril vs. telmisartan vs. both in CVD, stroke, PAD, or DM | * [[ONTARGET]] (2008): Ramipril vs. telmisartan vs. both in CVD, stroke, PAD, or DM | ||
* [[TREAT]] (2009): Darbepoetin in CKD and T2DM | * [[TREAT]] (2009): Darbepoetin in CKD and T2DM | ||
* [[VA-NEPHRON D]] (2013): ACE+ARB in DM nephropathy | * [[VA-NEPHRON D]] (2013): ACE+ARB in DM nephropathy | ||
Line 1,022: | Line 1,013: | ||
* [[POISE]] (2008): Perioperative metoprolol | * [[POISE]] (2008): Perioperative metoprolol | ||
* [[SYNTAX]] (2009): PCI vs. CABG in severe CAD | * [[SYNTAX]] (2009): PCI vs. CABG in severe CAD | ||
'''Emphysema''' | '''Emphysema''' | ||
Line 1,031: | Line 1,019: | ||
'''Meniscal Tear''' | '''Meniscal Tear''' | ||
* [[METEOR]] (2013): Surgery vs. PT in OA with meniscal tear | * [[METEOR]] (2013): Surgery vs. PT in OA with meniscal tear | ||
'''Osteoarthritis''' | '''Osteoarthritis''' |